LifeMD, Inc.

LifeMD, Inc.

LFMDยทNASDAQ

$4.56

+2.8%
HealthcareMedical - Pharmaceuticals

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$220.53M
EPS-0.2300
P/E Ratio-19.83
Earnings Date08/04/2026
3Y-136.0%
5Y-168.0%
10Y-2130.0%
3Y-150.0%
5Y-966.0%
10Y+3042.0%
3Y+2438.0%
5Y-164.0%
10Y-3850.0%
LFMD

LifeMD, Inc. Cash Conversion Engine

LFMD ยท NASDAQ
Net Income15.62M
Depreciation & Amortization328.37K
Stock-Based Compensation10.50M
Change in Working Capital-7.85M
Others-10.31M
Capital Expenditures-1.87M
Free Cash Flow6.41M

Cash Flow Quality Analysis

FCF Conversion Rate

41.0%

Weak cash conversion. Significant portion of earnings not converting to cashโ€”review working capital trends and capital intensity.

CapEx Intensity

22.6%

Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.

FCF Growth Trend

+7.2%

Steady FCF growth indicates consistent cash generation improvement. On a positive trajectory.

Working Capital Impact

-$7.85M

Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extensionโ€”monitor closely.

Cash Flow Quality Insight

Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.

LifeMD, Inc. Cash Flow Statement

LFMD โ€ข NASDAQ

LifeMD, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011
OPERATING ACTIVITIES
15.6M
-18.7M
-20.6M
-45M
-61.3M
-60.5M
-3.5M
-1.4M
-1.2M
-1.2M
-159.2K
-460.5K
-268.3K
-445.6K
-502.9K
328.4K
9.5M
6.6M
3.8M
868.8K
397.8K
335.6K
195.8K
91.6K
33.7K
43.7K
57K
57K
57K
56.7K
0.0
0.0
0.0
354K
0.0
914.9K
66K
4K
-90.3K
37.4K
-13.2K
-17.2K
-17.2K
-17.2K
-17.2K
10.5M
12.2M
12.5M
13.7M
12.1M
18.7M
733.2K
273.6K
162.7K
588K
142.3K
125.5K
105K
84K
400K
-10.3M
1.9M
5.4M
5.8M
6.2M
19.6M
578.6K
237.2K
918K
33.7K
-127.3K
80.5K
48.8K
122.3K
-17.2K
-7.9M
12.6M
4.9M
-1.5M
9.1M
8.8M
2.1M
-256K
-693.3K
122.5K
-181.5K
328.6K
-184.3K
-30.2K
45.8K
8.3M
17.5M
8.8M
-22.9M
-33.1M
-12.1M
251.4K
-905.5K
-817.2K
-407.9K
-295.1K
33.4K
-259.1K
-229.7K
-17.7K
INVESTING ACTIVITIES
(0.0)
-1.5M
-203.8K
-366.6K
-247.4K
-398.1K
(0.0)
-100K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-1M
(0.0)
-400K
-100K
(241.4K)
(63.4K)
(219.9K)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
127.3K
0.0
0.0
0.0
0.0
6.9M
-10M
-8.5M
-12.5M
-3.2M
0.0
-100K
290K
0.0
0.0
127.3K
0.0
0.0
0.0
0.0
(6.9M)
-11.5M
-8.7M
-13.9M
-3.4M
-798.1K
-100K
(141.4K)
(63.4K)
(219.9K)
(127.3K)
(0.0)
(0.0)
(0.0)
(0.0)
FINANCING ACTIVITIES
9.2M
0.0
16.2M
0.0
14M
17.2M
350K
0.0
596.6K
-23.8K
-10.8K
0.0
175K
345.9K
193.5K
-18.7M
-327.6K
16.7M
2.7M
-530.8K
93.2K
798.3K
642.4K
116.1K
131.4K
158K
-13K
40.2K
-50.7K
-142.3K
-3.1M
-3.1M
-3.1M
-3.1M
-871.5K
-1.3M
(0.0)
(0.0)
(0.0)
(0.0)
-10.8K
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-76.6K
-87.1K
-10.8K
(0.0)
(0.0)
(0.0)
(0.0)
-773.7K
-684.8K
-667.6K
-159.2K
707.4K
2.1M
-373.2K
160.3K
63.4K
249.9K
189K
-100K
100K
0.0
0.0
-13.4M
-4.1M
29.1M
-528.2K
68.6M
21M
775.1K
802.8K
776K
357.5K
325.4K
-113K
315.2K
295.2K
51.2K
CASH FLOW SUMMARY
1.8M
1.9M
29.2M
-37.4M
32.1M
8.1M
926.5K
38.7K
-41.2K
-50.4K
157.5K
-79.6K
56.1K
65.4K
33.5K
35M
33.1M
4M
41.3M
9.2M
1.1M
180.1K
141.4K
182.6K
233K
75.5K
155.1K
98.9K
33.5K
0.0
36.8M
35M
33.1M
4M
41.3M
9.2M
1.1M
180.1K
141.4K
182.6K
233K
75.5K
155.1K
98.9K
33.5K
6.4M
6M
86.9K
-35.8M
-36.5M
-12.5M
251.4K
-1M
-817.2K
-407.9K
-295.1K
33.4K
-259.1K
-229.7K
-17.7K

SEC Filings

LFMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 06, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 06, 2026
May 06, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 30, 2026
April 30, 2026
2026
8-K

8-K 2026

N/A

March 18, 2026
March 16, 2026
2026
10-K

10-K 2025 FY

FY

March 10, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

March 09, 2026
March 09, 2026
2026
8-K

8-K 2026

N/A

January 06, 2026
January 02, 2026
2026
8-K

8-K 2025

N/A

November 17, 2025
November 17, 2025
2025
10-Q

10-Q 2025 Q3

Q3

November 17, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 05, 2025
November 05, 2025
2025
Showing 1 to 10 of 225 filings